Work

Phase I Trial of G3139, a bcl-2 Antisense Oligonucleotide, Combined With Doxorubicin and Cyclophosphamide in Children With Relapsed Solid Tumors: A Children's Oncology Group Study

Year: 2007

Type: article

Study design: Clinical Trial

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2006.09.5125

Authors: Susan R. Rheingold, Michael D. Hogarty, Susan M. Blaney, James A. Zwiebel, Calies Sauk-Schubert, Reddy Chandula, Mark D. Krailo, Peter C. Adamson

Institutions: University of Southern California, Children's Hospital of Philadelphia, Baylor College of Medicine

Language: English

Topic: Cell death mechanisms and regulation

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Cancer Institute, National Center for Research Resources

Awards: G1325384987, G27536180, G305172255, G3180641672, General Clinical Research Center, General Clinical Research Center, General Clinical Research Center, General Clinical Research Center, Children's Oncology Group Phase 1 / Pilot Consortium, G71706220, General Clinical Research Center

OpenAlex ID: W2171751908

FWCI: 1.853

Cites: 34

Cited by: 39

Related to: 10